PATIENTS AND METHODS: A point prevalence survey (PPS) was conducted in the children's wards of 14 tertiary care hospitals in Punjab Province, covering over 50% of the population of Pakistan. This builds on a previous PPS among tertiary care hospitals treating exclusively neonates and children.
RESULTS: A total of 1811 neonates and children were surveyed with 1744 patients prescribed antibiotics, a prevalence of 96.3%. A total of 2747 antibiotics were prescribed to these 1744 neonates and children, averaging 1.57 antibiotics per patient. Overall, 57.7% of the patients were prescribed one antibiotic and 27.2% two antibiotics, with 85.6% of antibiotics administered parenterally. Over a third (34.4%) of the antibiotics were prescribed prophylactically, with 44.7% of them for surgical procedures. Among those prescribed antibiotics for surgical procedures, 75.2% were prescribed for more than one day. Overall, 92.2% of antibiotics were prescribed empirically, with 86.2% prescribed without mentioning the rationale for their choice in the notes, with 77.6% having no stop date. Respiratory tract infections were the most common indication (43.4%). Staphylococcus species (36.0%) were the most common pathogen with limited Culture and Sensitivity Testing performed. Three quarters (75.2%) of antibiotics were from the Watch list, and 24.4% were Access antibiotics.
CONCLUSION: A very high prevalence of antibiotic use among neonates and children in tertiary hospitals in Pakistan, including Watch antibiotics, mirroring previous studies. Consequently, initiatives including antimicrobial stewardship programmes are urgently needed to address current inappropriate prescribing.
METHODS: AgNP-SC was synthesised by reducing silver nitrate with an aqueous extract of S. crispus, with nanoparticle formation indicated by the appearance of a dark brown colour. Cytotoxicity was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Apoptotic changes were examined through acridine orange/propidium iodide (AO/PI) staining, while cell cycle distribution was analysed using flow cytometry. Gene expression of apoptotic markers was analysed using reverse transcription polymerase chain reaction (RT-PCR).
RESULTS: MTT analysis demonstrated a significant, concentration-dependent decrease in CT26 cell viability following AgNP-SC treatment, with cell viability reduced to below 50% at concentrations ≥ 25 μg/mL (P < 0.05). AO/PI staining revealed classical apoptotic features, including chromatin condensation, membrane blebbing, and nuclear fragmentation. Flow cytometric analysis showed a significant accumulation of cells in the G1 phase accompanied by a marked reduction in the S-phase population in treated groups compared to untreated controls (P < 0.05), indicating G1 cell cycle arrest and inhibition of DNA synthesis. RT-PCR analysis further demonstrated significant upregulation of pro-apoptotic genes (CED-3 and CED-4) and downregulation of the anti-apoptotic gene CED-9 (P < 0.05), confirming activation of the intrinsic mitochondrial apoptotic pathway.
CONCLUSION: Green-synthesised AgNP-SC exhibits potent anticancer properties, suggesting its potential as a natural-based nanotherapeutic agent for colon cancer. Further in vivo and mechanistic studies are warranted to validate its therapeutic efficacy.